The 8 best-selling COVID-19 vaccines and drugs in the first quarter of 2021 are:
#1. Pfizer-BioNTech COVID-19 vaccine. U.S. sales were $2.038 billion; global sales were $5.833 billion.
#2. Moderna COVID-19 vaccine. U.S. sales, $1.358 billion; global sales, $1.733 billion.
#3. Gilead Sciencesā remdesivir (Veklury). An antiviral drug, U.S. sales for the quarter were $820 million; global sales, $1.456 billion.
#4. Eli Lillyās bamlanivimab and etesevimab. The antibody cocktail brought in $650.6 million in U.S. sales in the first quarter.
#5. Regeneron Pharmaceuticalsā casirivimab and imdevimab (REGEN-COV). Regeneronās antibody cocktail reported $262 million in Q1 U.S. sales and $438.8 million globally.
#6. AstraZeneca-Oxford COVID-19 vaccine. No U.S. sales (not yet submitted for authorization); global sales of $275 million for the first quarter.
#7. Sinovac Biotechās CoronaVac (vaccine). No U.S. sales. First-quarter global sales were $264.5 million.
#8. Johnson & Johnsonās single-shot COVID-19 vaccine. For the first quarter, $100 million in U.S. sales.